ARQT icon

Arcutis Biotherapeutics
ARQT

50 hedge funds and large institutions have $974M invested in Arcutis Biotherapeutics in 2020 Q1 according to their latest regulatory filings, with 50 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
50
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$314M
2
+$170M
3
+$139M
4
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$119M
5
VC
Vivo Capital
California
+$50.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$314M
2
$170M
3
$139M
4
$119M
5
$50.3M
6
$34.7M
7
$29.2M
8
$25.8M
9
$25.2M
10
$12.3M
11
$11.2M
12
$7.58M
13
$5.95M
14
$5.23M
15
$4.99M
16
$3.23M
17
$2.05M
18
$1.8M
19
$1.66M
20
$1.49M
21
$1.23M
22
$1.16M
23
$718K
24
$668K
25
$657K
1
2